Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
8
Number of overlapping holdings
21.6%
% of BHCHX's 40 holdings also in HRTS
20.5%
% of HRTS's 39 holdings also in BHCHX
Overlap by Weight
Sector Drift (BHCHX minus HRTS)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BHCHX |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY AND COMPANY | 9.3% | 7.2% | 7.2% |
|
VERTEX PHARMACEUTICALS INCORPORATED | 4.6% | 5.8% | 4.6% |
|
BOSTON SCIENTIFIC CORPORATION | 5.3% | 2.6% | 2.6% |
|
DEXCOM, INC. | 1.7% | 2.8% | 1.7% |
|
EDWARDS LIFESCIENCES CORPORATION | 1.6% | 2.3% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
BHCHX Overweight Relative to HRTS
|
UNITEDHEALTH GROUP INCORPORATED | 7.3% |
|
INTUITIVE SURGICAL, INC. | 5.8% |
|
MERCK & CO., INC. | 4.8% |
|
THERMO FISHER SCIENTIFIC INC | 4.7% |
 |
ARGENX SE ADR | 4.1% |
 |
ICON PLC | 3.2% |
|
STRYKER CORPORATION | 3.2% |
|
ELEVANCE HEALTH, INC. | 2.7% |
|
MCKESSON CORPORATION | 2.7% |
|
BOSTON SCIENTIFIC CORPORATION | 2.7% |
BHCHX Underweight Relative to HRTS
|
ALNYLAM PHARMACEUTICALS INC | -5.0% |
|
BRIDGEBIO PHARMA, INC. | -4.2% |
 |
NOVO NORDISK A/S-B | -3.9% |
|
CRINETICS PHARMACEUTICALS INC | -3.8% |
|
AMGEN INC | -3.8% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.7% |
 |
ASTRAZENECA PLC | -3.6% |
|
ASCENDIS PHARMA A/S | -3.5% |
|
CYTOKINETICS INC | -3.3% |
|
MASIMO CORPORATION | -2.8% |